肺部疾病
Lung Diseases

百靈佳殷格翰在呼吸系統疾病治療領域擁有 100 年的悠久歷史。自 1921 年以來,我們已成為該疾病治療領域的領導者,在呼吸系統疾病中推出了多種治療方法,包括針對氣喘、肺阻塞(舊稱慢性阻塞性肺病)、肺纖維化 (IPF + ILD) 和肺癌。我們的努力在提升這使人衰弱的呼吸系統疾病的的罹病後生活品質,並使他們能夠保持更獨立的生活。

Boehringer Ingelheim has 100 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area, having launched several treatments in a range of respiratory conditions including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and lung cancer. Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life.

 

lib-org-D3pZd677.jpg
100-year-anniversary-0.jpg

百靈佳殷格翰 呼吸道100年
100-year anniversary

1921 年,百靈佳殷格翰帶著改變呼吸道疾病治療世界的願景出發,而2021 年的到來,代表著我們 100 年來不斷突破科學創新的界限。
In 1921, Boehringer Ingelheim set out with a vision to transform the world of respiratory care. 2021 marks the company looks back on 100 years of pushing the boundaries in scientific

An Overview of Respiratory
Ivan-Blahanik-0.jpg
肺部疾病

An Overview of Respiratory

Ivan Blanarik, Therapeutic Area Head Respiratory at Boehringer Ingelheim
更多資訊
An Expert’s Insight into Systemic Sclerosis
Professor-Denton-SSc2.jpeg
肺部疾病

An Expert’s Insight into Systemic Sclerosis

In this new video listen to consulant rheumatlogist Professor Denton discuss his experience diagnosing systemic sclerosis
更多資訊
products_a_to_z

詳列我們目前的人類處方用藥
A complete overview of our products for Human Health.